Title: Assessment of 213Bi-anti-EGFR-MAb treatment response in malignant cancer cells
Authors: FEUERECKER BENEDIKTRANDL PHILIPPSEIDL C.BRUCHERTSEIFER FRANKMORGENSTERN ALFREDSCHWAIGER M.EISENREICH WOLFGANG
Publisher: European Commission - Joint Research Centre
Publication Year: 2017
JRC N°: JRC105961
URI: http://nucmed.w3.kanazawa-u.ac.jp/symposium/tat10/
http://publications.jrc.ec.europa.eu/repository/handle/JRC105961
Type: Articles in periodicals and books
Abstract: Evaluation of response to treatment is among the major challenges in oncology. Using a targeted therapy approach with an alpha-particle emitting radionuclide we investigated two different tumor cell lines with regard to alterations in glycolysis as measure of therapy response. Hereby, in vitro assays represent a valuable tool to provide necessary information about therapeutic efficacy.
JRC Directorate:Nuclear Safety and Security

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.